Learn how an immutable ledger uses hashes and chained timestamps to create tamper‑evident records, strengthen digital trust, and protect critical transactions from hidden tampering. Pixabay, Openclay ...

SALT LAKE CITY (KUTV) — A “Fight the Trump Takeover” rally took place outside the Wallace F. Bennett Federal Building in downtown Salt Lake City on Saturday. Protesters arrived with signs and flags in ...

A distillery in Sayville is using locally produced sea salt from Amagansett to enhance the flavors of their spirits and create better cocktails, including their own line of premium canned cocktails.

Some 2,000 Salvadorans created a colorful carpet made of dyed salt stretching 1,070 meters, which was used for the Holy Burial procession on Friday night, organizers reported Saturday. The “mega ...

Add Yahoo as a preferred source to see more of our stories on Google. When you’re on the go early in the day, whether it’s your daily commute or a road-trip situation, there’s nothing more comforting ...

This voice experience is generated by AI. Learn more. This voice experience is generated by AI. Learn more. Pills, tablets and capsules on world map with charts blue background. International ...

Three cartons of McDonald's french fries on tray with other food and beverages - In Green/Shutterstock The secret to the delicious flavor of McDonald's fries lies in the chain's meticulous frying and ...

Generate:Biomedicines is the latest biotech to benefit from a renewed appetite from investors for publicly listed drug developers. Generate—which will list its stock on the Nasdaq this morning under ...

Feb 26 (Reuters) - Generate Biomedicines said on Thursday that it raised $400 million in its U.S. initial public offering, pricing shares of the U.S.-based drug developer at $16 each. The offering ...

Feb 23 (Reuters) - Drug developer Generate Biomedicines said on Monday it was targeting a valuation of up to $2.17 billion in its U.S. initial public offering, tapping into a resurgent biotech market ...

Generate Biomedicines Inc., a biotechnology firm using artificial intelligence in drug development, is seeking to raise as much as $425 millon in an initial public offering, as listing activity in the ...